The policy analysis and guidance you need by the experts you trust, daily.
- After Hours
- Agent Oversight
- Brain Food
- Health Insurance Exchanges
- Part D
- Performance Optimization
- Policy & Health Reform
- Prospective Evaluations
- Provider Relations
- Risk Adjustment
- Sales & Marketing
- Star Ratings
- Alan Mittermaier on MA and Part D Proposed Rule Increases Plan Flexibility, Reduces Regulatory Burden
- Sharon Willliams on A New Source of Capital for Star Ratings and Clinical Innovations
- William on Will Trump and Price Pull Out the Scalpels for Star Ratings?
- Bobby on January Release of the Draft MMG – Perfect Timing
- Pam Lassila on Best Practices and Common Conditions of Audit Preparation
The Voice of Melissa Smith
With the much anticipated Advance Notice now in hand, we have our first glimpse into the Centers for Medicare & Medicaid Services (CMS) proposed changes to the 2019 and 2020 Star Ratings. Though CMS hasn’t yet proposed any noteworthy changes (or removed any measures) as part of its “Meaningful Measures” or “Patients Over Paperwork” initiatives, there are plenty of proposals to be carefully considered. Here’s a quick summary of CMS’ proposals impacting the 2019 Star Ratings: Read more
With comments on the Medicare Advantage (MA) and Prescription Drug Benefit Program (Part D) Proposed Rule for 2019 due by January 16, 2018, we’ve received numerous requests for help distilling the Stars elements from the Centers for Medicare & Medicaid Services (CMS’) 713 pages of proposed regulations. Yep, we’ve read all 713 pages, and CMS is seeking feedback on numerous potential adjustments to the Star Ratings programs in the coming years. CMS has, and continues to, demonstrate its willingness to consider plan feedback on proposed changes, and plans should seize this opportunity to be “on the record” so CMS can make well-informed decisions as it adjusts the program in the coming years.